TY  - CHAP
M1  - Book, Section
TI  - Chapter 8. Follow-Up Evaluation
A1  - Cipolle, Robert J.
A1  - Strand, Linda M.
A1  - Morley, Peter C.
A2  - Cipolle, Robert J.
A2  - Strand, Linda M.
A2  - Morley, Peter C.
Y1  - 2012
N1  - 
T2  - Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management Services, 3e
AB  - The  purpose  of  the  follow-up  evaluation  is  to  determine  the  patient's  outcomes  in  relation  to  the  desired  goals  of  therapy.Parameters  that  reflect  both  effectiveness  and  drug  safety  are  evaluated  at  each  follow-up  visit.The  evaluation  of  effectiveness  of  pharmacotherapy  includes  measurable  improvement  in  clinical  signs  and  symptoms  and/or  laboratory  values.The  evaluation  of  the  safety  of  pharmacotherapy  includes  evidence  of  adverse  drug  reactions  and/or  toxicity.Patient  adherence  and  its  influence  on  outcomes  are  determined  during  the  follow-up  evaluation.The  outcome  status  of  the  patient's  medical  condition  being  treated  or  prevented  with  drug  therapy  is  determined  and  described.The  patient  is  reassessed  to  determine  if  any  new  drug  therapy  problems  have  developed  since  the  last  follow-up  visit.The  follow-up  evaluation  is  the  step  in  which  actual  results  and  outcomes  from  drug  therapies  are  documented.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/23
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=56173564
ER  -